LIPO-202 is an injectable formulation of salmeterol xinafoate, a long-acting ß2-adrenergic receptor agonist used in several FDA-approved drugs, including Advair, which is indicated to treat asthma. In the
This US based trial will be conducted under the active investigational new drug (IND) application on file with the US Food and Drug Administration (FDA). Around 180 patients
Ozoralizumab includes two nanobodies targeting TNFa, which are linked to a nanobody that binds to human serum albumin, extending the drug’s half-life and improving its distribution to inflamed
The collaboration is designed to identify combination regimens that provide synergies in efficacy and durability in patients with metastatic cutaneous and uveal melanomas. IMCgp100 is Immunocore’s lead T
Dextromethorphan is designed to treat cough due to minor throat and bronchial irritation. As part of the deal, Tris will be responsible for manufacturing and regulatory activities, while
Trevyent is SteadyMed’s lead drug product candidate currently under development stage that combines its PatchPump technology with treprostinil, a vasodilatory prostacyclin analogue to treat PAH. As part of
The deal will see the firms use T cell therapeutic strategies to develop treatments for these patients with an initial focus on Chimeric Antigen Receptor Technology (CAR-T) and
Currently, Tivorbex capsules are now available by prescription at pharmacies across the country. Tivorbex 20mg and 40mg dosage strengths are 20% lower than the 25mg and 50mg indomethacin
TriCalm Hydrogel was the company’s initial product in itch-relief product line and these two new products strategically expand the brand’s line of steroid-free, anti-itch products to further benefit
Spinifex is focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a new angiotensin II Type 2 receptor (AT2R) antagonist. EMA401 is being developed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.